Please Wait.....
Report
Melanoma Therapeutics Market (Therapy Type: Chemotherapy, Immunotherapy, targeted Therapy, Radiation Therapy, and Surgery; and Disease Indication: Superficial Spreading Melanoma, Nodular Melanoma, Lentigo Maligna Melanoma, Acral Lentiginous Melanoma, and Desmoplastic Melanoma) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
Market Report I 2024-07-08 I 156 Pages I Transparency Market Research
Melanoma Therapeutics Market - Scope of Report
TMR's report on the global melanoma therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global melanoma therapeutics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global melanoma therapeutics market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the melanoma therapeutics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global melanoma therapeutics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global melanoma therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global melanoma therapeutics market.
The report delves into the competitive landscape of the global melanoma therapeutics market. Key players operating in the global melanoma therapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global melanoma therapeutics market profiled in this report.
Key Questions Answered in Global melanoma therapeutics Market Report
- What is the sales/revenue generated by melanoma therapeutics across all regions during the forecast period?
- What are the opportunities in the global melanoma therapeutics market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Melanoma Therapeutics Market - Research Objectives and Research Approach
The comprehensive report on the global melanoma therapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global melanoma therapeutics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global melanoma therapeutics market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Melanoma Therapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Melanoma Therapeutics Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Melanoma Therapeutics Market Analysis and Forecast, by Therapy Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Therapy Type, 2020-2034
6.3.1. Chemotherapy
6.3.2. Immunotherapy
6.3.3. Targeted Therapy
6.3.4. Radiation Therapy
6.3.5. Surgery
6.4. Market Attractiveness Analysis, by Therapy Type
7. Global Melanoma Therapeutics Market Analysis and Forecast, by Disease Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Disease Indication, 2020-2034
7.3.1. Superficial Spreading Melanoma
7.3.2. Nodular Melanoma
7.3.3. Lentigo Maligna Melanoma
7.3.4. Acral Lentiginous Melanoma
7.3.5. Desmoplastic Melanoma
7.4. Market Attractiveness Analysis, by Disease Indication
8. Global Melanoma Therapeutics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals & Specialty Clinics
8.3.2. Homecare Settings
8.3.3. Others (Academic Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Melanoma Therapeutics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Melanoma Therapeutics Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Therapy Type, 2020-2034
10.3.1. Chemotherapy
10.3.2. Immunotherapy
10.3.3. Targeted Therapy
10.3.4. Radiation Therapy
10.3.5. Surgery
10.4. Market Value Forecast, by Disease Indication, 2020-2034
10.4.1. Superficial Spreading Melanoma
10.4.2. Nodular Melanoma
10.4.3. Lentigo Maligna Melanoma
10.4.4. Acral Lentiginous Melanoma
10.4.5. Desmoplastic Melanoma
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals & Specialty Clinics
10.5.2. Homecare Settings
10.5.3. Others (Academic Institutes, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Therapy Type
10.7.2. By Disease Indication
10.7.3. By End-user
10.7.4. By Country
11. Europe Melanoma Therapeutics Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Therapy Type, 2020-2034
11.3.1. Chemotherapy
11.3.2. Immunotherapy
11.3.3. Targeted Therapy
11.3.4. Radiation Therapy
11.3.5. Surgery
11.4. Market Value Forecast, by Disease Indication, 2020-2034
11.4.1. Superficial Spreading Melanoma
11.4.2. Nodular Melanoma
11.4.3. Lentigo Maligna Melanoma
11.4.4. Acral Lentiginous Melanoma
11.4.5. Desmoplastic Melanoma
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals & Specialty Clinics
11.5.2. Homecare Settings
11.5.3. Others (Academic Institutes, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Therapy Type
11.7.2. By Disease Indication
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Melanoma Therapeutics Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Therapy Type, 2020-2034
12.3.1. Chemotherapy
12.3.2. Immunotherapy
12.3.3. Targeted Therapy
12.3.4. Radiation Therapy
12.3.5. Surgery
12.4. Market Value Forecast, by Disease Indication, 2020-2034
12.4.1. Superficial Spreading Melanoma
12.4.2. Nodular Melanoma
12.4.3. Lentigo Maligna Melanoma
12.4.4. Acral Lentiginous Melanoma
12.4.5. Desmoplastic Melanoma
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals & Specialty Clinics
12.5.2. Homecare Settings
12.5.3. Others (Academic Institutes, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Therapy Type
12.7.2. By Disease Indication
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Melanoma Therapeutics Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Therapy Type, 2020-2034
13.3.1. Chemotherapy
13.3.2. Immunotherapy
13.3.3. Targeted Therapy
13.3.4. Radiation Therapy
13.3.5. Surgery
13.4. Market Value Forecast, by Disease Indication, 2020-2034
13.4.1. Superficial Spreading Melanoma
13.4.2. Nodular Melanoma
13.4.3. Lentigo Maligna Melanoma
13.4.4. Acral Lentiginous Melanoma
13.4.5. Desmoplastic Melanoma
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals & Specialty Clinics
13.5.2. Homecare Settings
13.5.3. Others (Academic Institutes, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Therapy Type
13.7.2. By Disease Indication
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Melanoma Therapeutics Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Therapy Type, 2020-2034
14.3.1. Chemotherapy
14.3.2. Immunotherapy
14.3.3. Targeted Therapy
14.3.4. Radiation Therapy
14.3.5. Surgery
14.4. Market Value Forecast, by Disease Indication, 2020-2034
14.4.1. Superficial Spreading Melanoma
14.4.2. Nodular Melanoma
14.4.3. Lentigo Maligna Melanoma
14.4.4. Acral Lentiginous Melanoma
14.4.5. Desmoplastic Melanoma
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals & Specialty Clinics
14.5.2. Homecare Settings
14.5.3. Others (Academic Institutes, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Therapy Type
14.7.2. By Disease Indication
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Bristol-Myers Squibb Company
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. AstraZeneca plc
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Novartis AG
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Merck & Co., Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Amgen Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. F. Hoffmann-La Roche AG
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Abbott Laboratories
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
List of Tables
Table 01: Global Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
Table 02: Global Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 03: Global Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 04: Global Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
Table 07: North America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 08: North America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 09: Europe Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
Table 11: Europe Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 12: Europe Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
Table 15: Asia Pacific Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 16: Asia Pacific Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 17: Latin America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
Table 19: Latin America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 20: Latin America Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Therapy Type, 2020-2034
Table 23: Middle East & Africa Melanoma Therapeutics Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 24: Middle East & Africa Melanoma Therapeutics Market Size (US$ Bn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Melanoma Therapeutics Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Melanoma Therapeutics Market Revenue (US$ Bn), by Therapy Type, 2023
Figure 03: Global Melanoma Therapeutics Market Value Share, by Therapy Type, 2023
Figure 04: Global Melanoma Therapeutics Market Revenue (US$ Bn), by Disease Indication, 2023
Figure 05: Global Melanoma Therapeutics Market Value Share, by Disease Indication, 2023
Figure 06: Global Melanoma Therapeutics Market Revenue (US$ Bn), by End-user, 2023
Figure 07: Global Melanoma Therapeutics Market Value Share, by End-user, 2023
Figure 08: Global Melanoma Therapeutics Market Value Share, by Region, 2023
Figure 09: Global Melanoma Therapeutics Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
Figure 11: Global Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 13: Global Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 14: Global Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Melanoma Therapeutics Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Melanoma Therapeutics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Melanoma Therapeutics Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Melanoma Therapeutics Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
Figure 22: North America Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 23: North America Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 26:North America Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Melanoma Therapeutics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Melanoma Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Melanoma Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
Figure 31: Europe Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 32: Europe Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 35: Europe Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Melanoma Therapeutics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Melanoma Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Melanoma Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
Figure 40: Asia Pacific Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 41: Asia Pacific Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 44: Asia Pacific Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Melanoma Therapeutics Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Melanoma Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Melanoma Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
Figure 49: Latin America Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 50: Latin America Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 53: Latin America Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Melanoma Therapeutics Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Melanoma Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Melanoma Therapeutics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Melanoma Therapeutics Market Value Share Analysis, by Therapy Type, 2023 and 2034
Figure 58: Middle East & Africa Melanoma Therapeutics Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 59: Middle East & Africa Melanoma Therapeutics Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Melanoma Therapeutics Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Melanoma Therapeutics Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 62: Middle East & Africa Melanoma Therapeutics Market Attractiveness Analysis, by End-user, 2024-2034
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security